Skip to main content

Table 2 General characteristics and outcomes of the included studies (n = 38)

From: Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000–2022: a systematic review and meta-analysis

No

Author and year

Country

Sample size

Study design

P (%)

Shypo

Hypo

Shyper

Hyper

Study quality

1

Zhu, Y. et al. (2019) [26]

China

1677

Cross sectional

23.79

4.89

9.3

1.13

3.16

Good

2

Vamshidhar et al. (2020) [16]

India

50

Cross sectional

16

8

6

0

2

Good

3

Tudor, R. M. et al. (2018) [10]

Ireland

618

Cohort

30.5

15.5

3.5

9.7

1.8

Good

4

Subekti, I. et al. (2017) [11]

Indonesia

303

Cross sectional

9.9

0

7.59

0

2.31

Good

5

Papazafiropoulou, A. et al. (2010) [27]

Greek

1092

Cross sectional

12.3

    

Good

6

Palma, C. C. et al. (2013) [22]

Brazil

304

Cross sectional

13.3

12

0.7

0.3

0.3

Good

7

Ogbonna, S. U. et al. (2019) [28]

Nigeria

354

Cross sectional

12.4

0

11.6

0

0.8

Good

8

Khatiwada, S. et al. (2015) [29]

Nepal

401

Cross sectional

35.4

0

31.17

0

4.05

Good

9

Khassawneh, A. H. et al. (2020) [42]

Jordan

998

Case control

26.7

12.5

9.5

2.3

2.3

Good

10

Díez, J. J. et al. (2011) [7]

India

75

Cross sectional

25.2

14.6

8

1.3

1.3

Good

11

Demitrost, L. et al. (2012) [48]

India

202

Retrospective study

31.2

16.3

11.4

2

1.5

Good

12

Al-Wazzan, H. et al. (2010) [36]

Kuwait

1580

CS and CC

12.9

45.1

20.1

13.2

5.9

Good

13

Al-Geffari, M. et al. (2013) [23]

Saudi

411

Cross sectional

28.5

9.5

15.8

2.7

0.5

Good

14

Radaideh, A. et al. (2004) [30]

Jordan

908

Cross sectional

12.5

4

6.2

1.2

4

Good

15

Vikhe, V. B. et al. (2013) [9]

India

50

Case control

30

14

22

6

2

Good

16

Yadav, A. et al. (2021) [47]

India

2219

Cohort

20.3

14.1

3.2

0

3

Good

17

Peters, K. E. et al. (2020) [46]

Australia

1408

Cohort

16.8

    

Good

18

Ozair, M. et al. (2021) [31]

India

250

Cross-sectional

28

18.8

8

0

1.2

Good

19

Elgazar, E. H. et al. (2019) [32]

Egypt

200

Cross sectional

29

13

7

3

6

Good

20

Moslem, F. et al. (2015) [14]

Bangladesh

232

Cross sectional

10

    

Good

21

Sarfo-Kantanka O. et al. (2017) [43]

Ghana

302

Case control

12.2

    

Good

22

Ghazali S. M. et al. (2010) [40]

Nigeria

64

Case control

29.7

15.8

0

5.2

0

Good

23

Jalal M. J. et al. (2019) [39]

India

50

Case control

16

10

6

0

0

Good

24

Akbar D. H. et al. (2006) [41]

Saudi

74

Case control

9.5

6.75

2.7

0

0

Good

25

Hussain T. et al. (2019) [45]

India

700

Prospective

21.7

8

9.3

2.1

2.3

Good

26

Younes Y. R. (2020) [33]

Iraq

90

Cross sectional

17.7

11.1

3.3

1.1

2.2

Good

27

Jugati A., Biradar M. (2018) [51]

India

200

Case series

25

13.5

5.5

2.5

3.5

Good

28

Haque S. I. U. et al. (2019) [34]

Pakistan

334

Cross sectional

30.3

15.6

2.7

10.2

1.8

Good

29

Elmenshawi I. et al. (2017) [49]

Egypt

100

Retrospective study

29

23

3

0

3

Good

30

Al-Lehibi K. I. et al. (2019) [50]

Iraq

1341

Retrospective study

8

0

7

0

1

Good

31

Noori D. A. S. et al. (2019) [38]

Iraq

75

Case control

13.3

4

6.6

1.3

1.3

Good

32

Ahmed A. A. et al. (2017) [3]

Libya

369

Cross sectional

9.5

5

2.3

0

2.2

Good

33

Papanna J. et al. (2019) [8]

India

100

Cross sectional

32

18

8

1

5

Good

34

Mausam Jain et al. (2020) [35]

India

263

Cross sectional

25.44

5.7

14.8

1.9

3.04

Good

35

Jain G. et al. (2013) [37]

India

200

Cross sectional

16

7.5

4.5

1.5

2.5

Good

36

Padma V. et al. (2015) [44]

India

100

Case control

29

16

10

2

1

Good

37

Vij V. et al. (2014) [53]

India

40

Case control

25

15

10

0

0

Good

38

Aljabri K. S. (2019) [52]

Saudi

2069

Cross-sectional

20.7

3

11.1

6

1.6

Good

  1. Shypo subclinical hypothyroidism, Hypo hypothyroidism, Shyper subclinical hyperthyroidism, Hyper hyperthyroidism, CS and CC cross sectional and case control